1.9 percent of individuals reported cutaneous reaction after first dose of mRNA COVID-19 vaccine, most often rash and itching
Skin Rashes Occur in Considerable Number of SARS-CoV-2 Cases
17 percent of SARS-CoV-2-positive cases reported skin rash as first presentation; 21 percent had skin rash as only clinical sign